Logo

American Heart Association

  22
  0


Final ID: MP563

Artificial Intelligence-Based Coronary Artery Calcium (AI-CAC) Score Empowers the “Power of Zero”: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Abstract Body (Do not enter title and authors here): Background: The “Power of Zero” refers to the excellent negative predictive power of a coronary artery calcium (CAC) score of zero. Because CAC is currently reported using the Agatston score and this scoring method is based on a fixed radiologic density threshold (>130 HU) and minimum size (contiguous voxels >=1 mm2 in area), small or semi-calcified plaques are sometimes missed. We hypothesized AI-based coronary artery calcium (AI-CAC) scoring that does not require these fixed thresholds provides a superior predictive performance in individuals with an Agatston score of zero.

Methods: CAC scans and follow-up data (median [IQR]: 14.2 [13.6 – 14.8] years) from 3260 participants with an Agatston score of zero in the Multi-Ethnic Study of Atherosclerosis (MESA) baseline examination were analyzed (ages 57.9 ± 9.2 years, 62.8% female, 32.8% White, 30.9% Black, 24.4% Hispanic, 11.9% Chinese). AI-CAC scores were measured using AI-CVD automated coronary artery segmentation (HeartLung Technologies, Houston, TX). Voxels within the coronary segmentations were calibrated and standardized based on MESA’s phantom used during scanning. Voxels were additionally weighted based on the intensity of their in-plane neighbors. We examined the prognostic separation of AI-CAC=zero score versus Agatston=zero score with the cumulative incidence for myocardial infarction (MI), hard coronary heart disease (CHD) events, and all CHD events. Significant differences in proportions were calculated using the log-rank test or McNemar’s test for overlapping groups.

Results: AI-CAC provided a continuous range of values in individuals with Agatston=zero, revealing a previously unrecognized spectrum of semi-calcified plaque burden. 1,789 (54.6%) participants had an AI-CAC score of zero, and 1.485 (45.4%) had a non-zero score. In incident CHD cases, the mean ± SD for AI-CAC was 5.9 ± 11.6 and median (IQR) was 2.27 (0-5.5). There were significantly fewer MI, hard CHD and all-CHD events in AI-CAC=zero vs. Agatston=zero over 5, 10 and 15 years of follow up. Within the Agatston=zero population the AI-CAC>0 showed significantly higher event rates over AI-CAC=0. (See table below)

Conclusion: AI-CAC scores significantly improve on the negative predictive power of the Agatston CAC score of zero in MESA possibly by identifying small, semi-calcified or “soft” plaques. Future studies are warranted to corroborate these findings in other longitudinal cohorts.
  • Naghavi, Morteza  ( HeartLung Technologies , Houston , Texas , United States )
  • Vliegenthart, Rozemarijn  ( University Medical Center Groningen , Groningen , Netherlands )
  • Nasir, Khurram  ( Houston Methodist , Houston , Texas , United States )
  • Narula, Jagat  ( UTHealth Houston , Houston , Texas , United States )
  • Benjamin, Emelia  ( Boston University School Medicine , Brookline , Massachusetts , United States )
  • Levy, Daniel  ( Boston University , Boston , Massachusetts , United States )
  • Henschke, Claudia  ( Mount Sinai Hospital , New York , New York , United States )
  • Yankelevitz, David  ( Mount Sinai Hospital , New York , New York , United States )
  • Wong, Nathan  ( University of California, Irvine , Irvine , California , United States )
  • Atlas, Kyle  ( HeartLung Technologies , Houston , Texas , United States )
  • Zhang, Chenyu  ( HeartLung Technologies , Houston , Texas , United States )
  • Reeves, Anthony  ( Cornell University , Ithaca , New York , United States )
  • Atlas, Thomas  ( Tustin Teleradiology , Tustin , California , United States )
  • Wasserthal, Jakob  ( University Basel , Basel , Switzerland )
  • Mcconnell, Mike  ( Stanford University , Stanford , California , United States )
  • Maron, David  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Williams, Kim  ( University of Louisville Medicine , Louisville , Kentucky , United States )
  • Author Disclosures:
    Morteza Naghavi: DO have relevant financial relationships ; Ownership Interest:HeartLung.AI:Active (exists now) | Rozemarijn Vliegenthart: DO have relevant financial relationships ; Research Funding (PI or named investigator):Siemens Healthineers:Active (exists now) ; Speaker:Wiley:Past (completed) ; Speaker:Bayer Healthcare:Active (exists now) ; Speaker:Siemens Healthineers:Active (exists now) | Khurram Nasir: No Answer | Jagat Narula: DO NOT have relevant financial relationships | Emelia Benjamin: DO NOT have relevant financial relationships | Daniel Levy: No Answer | Claudia Henschke: No Answer | David Yankelevitz: DO have relevant financial relationships ; Royalties/Patent Beneficiary:General Electric:Active (exists now) ; Individual Stocks/Stock Options:Accumetra:Active (exists now) ; Advisor:Lunglife AI:Active (exists now) ; Advisor:Carestream:Active (exists now) ; Advisor:Median Technology:Active (exists now) ; Individual Stocks/Stock Options:HeartLung:Active (exists now) | Nathan Wong: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen, Novartis, Ionis:Active (exists now) ; Consultant:Ionis:Past (completed) ; Speaker:Novartis:Past (completed) ; Consultant:Heart Lung, Amgen, Novartis:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk, Regeneron:Past (completed) | Kyle Atlas: No Answer | Chenyu Zhang: DO have relevant financial relationships ; Employee:HeartLung Corporation:Active (exists now) ; Individual Stocks/Stock Options:HeartLung Corporation:Active (exists now) | Anthony Reeves: DO have relevant financial relationships ; Individual Stocks/Stock Options:HeartLung Technologies:Active (exists now) | Thomas Atlas: No Answer | Jakob Wasserthal: DO have relevant financial relationships ; Consultant:HeartLungAi:Active (exists now) | Mike McConnell: No Answer | David Maron: DO have relevant financial relationships ; Advisor:New Amsterdam:Past (completed) ; Individual Stocks/Stock Options:Ablative Solutions:Active (exists now) ; Consultant:Inno Med:Past (completed) ; Consultant:Scilex:Past (completed) ; Independent Contractor:J&J:Active (exists now) ; Consultant:Regeneron:Past (completed) ; Consultant:Hearlflow:Active (exists now) ; Research Funding (PI or named investigator):Omada Health:Active (exists now) ; Research Funding (PI or named investigator):Cleerly:Active (exists now) | Kim Williams: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Artificial Intelligence in Imaging and Multimodal Biomarkers: Advancing Precision Diagnostics and Prognostics

Saturday, 11/08/2025 , 09:15AM - 10:25AM

Moderated Digital Poster Session

More abstracts on this topic:
Aortic Valve Calcium as a Predictor of Chronic Kidney Disease in a Multi-Ethnic Cohort: The MESA Study

Abdollahi Ashkan, Rotter Jerome, Post Wendy, Blumenthal Roger, Bluemke David, Lima Joao Ac, Whelton Seamus, Sani Maryam, Shabani Mahsima, Scarpa Bruna, Blaha Michael, Wu Colin, Ambale-venkatesh Bharath, Budoff Matthew, Strom Jordan

Age Differences in Patients with Ischemia and Nonobstructive Coronary Arteries

Kostantinis Spyridon, García Castro Gabriel, Latif Nida, Cigarroa Natasha, Kunnirickal Steffne, Odanovic Natalija, Shah Samit

More abstracts from these authors:
AI-enabled Ascending Aorta and Pulmonary Trunk Volumetry in Coronary Artery Calcium Scans for Heart Failure Prediction: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wong Nathan, Wasserthal Jakob, Henschke Claudia, Yankelevitz David

AI-driven Aortic Valve Calcification Measurement in Coronary Artery Calcium Scan Detects Aortic Stenosis Comparably to Human Experts: An AI-CVD Study within the Framingham Heart Study

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wasserthal Jakob, Yankelevitz David, Henschke Claudia, Wong Nathan

You have to be authorized to contact abstract author. Please, Login
Not Available